TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9263740
log Bayes Factor = 20.6549
Chromosome 6   position 31,111,400  (GRCh37) Explore rs9263740 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.000 0.046 0.954
E83 Disorders of mineral metabolism
0.000 0.056 0.944
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.059 0.940
E70-E90 Metabolic disorders
0.000 0.062 0.938
E00-E07 Disorders of thyroid gland
0.007 0.064 0.929
E50-E64 Other nutritional deficiencies
0.000 0.068 0.932
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.071 0.929
E05 Thyrotoxicosis [hyperthyroidism]
0.001 0.072 0.926
E65-E68 Obesity and other hyperalimentation
0.000 0.086 0.914
E55 Vitamin D deficiency
0.000 0.094 0.906
E55.9 Vitamin D deficiency, unspecified
0.000 0.112 0.888
E66 Obesity
0.000 0.117 0.883
E53 Deficiency of other B group vitamins
0.000 0.121 0.879
E06 Thyroiditis
0.002 0.126 0.872
E66.8 Other obesity
0.000 0.139 0.861
L40.0 Psoriasis vulgaris
0.000 0.139 0.861
E53.8 Deficiency of other specified B group vitamins
0.000 0.164 0.836
E03 Other hypothyroidism
0.701 0.164 0.135
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.182 0.818
E06.9 Thyroiditis, unspecified
0.001 0.199 0.800
E85 Amyloidosis
0.000 0.232 0.768
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.235 0.765
E88 Other metabolic disorders
0.000 0.243 0.757
E65 Localised adiposity
0.000 0.249 0.751
E78.5 Hyperlipidaemia, unspecified
0.000 0.249 0.751
E06.3 Autoimmune thyroiditis
0.001 0.268 0.731
E66.0 Obesity due to excess calories
0.000 0.269 0.731
L40.4 Guttate psoriasis
0.000 0.283 0.717
L40.3 Pustulosis palmaris et plantaris
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.000 0.283 0.717
L40.1 Generalised pustular psoriasis
0.000 0.283 0.717
E78.2 Mixed hyperlipidaemia
0.000 0.302 0.698
E83.5 Disorders of calcium metabolism
0.000 0.305 0.695
E83.4 Disorders of magnesium metabolism
0.000 0.322 0.678
L40.8 Other psoriasis
0.000 0.322 0.678
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.323 0.677
E83.8 Other disorders of mineral metabolism
0.000 0.323 0.677
E83.2 Disorders of zinc metabolism
0.000 0.323 0.677
E83.0 Disorders of copper metabolism
0.000 0.323 0.677
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.326 0.674
E84 Cystic fibrosis
0.000 0.327 0.673
E79 Disorders of purine and pyrimidine metabolism
0.000 0.327 0.673
E77 Disorders of glycoprotein metabolism
0.000 0.327 0.673
E76 Disorders of glycosaminoglycan metabolism
0.000 0.327 0.673
E72 Other disorders of amino-acid metabolism
0.000 0.327 0.673
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.327 0.673
E70 Disorders of aromatic amino-acid metabolism
0.000 0.327 0.673
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.327 0.673
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.327 0.673
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.005 0.329 0.666
E00 Congenital iodine-deficiency syndrome
0.005 0.329 0.666
E85.4 Organ-limited amyloidosis
0.000 0.330 0.670
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.332 0.668
E63 Other nutritional deficiencies
0.000 0.332 0.668
E51 Thiamine deficiency
0.000 0.332 0.668
E50 Vitamin A deficiency
0.000 0.332 0.668
E60 Dietary zinc deficiency
0.000 0.332 0.668
E59 Dietary selenium deficiency
0.000 0.332 0.668
E58 Dietary calcium deficiency
0.000 0.332 0.668
E54 Ascorbic acid deficiency
0.000 0.332 0.668
E52 Niacin deficiency [pellagra]
0.000 0.332 0.668
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.333 0.666
E05.5 Thyroid crisis or storm
0.001 0.335 0.664
E05.4 Thyrotoxicosis factitia
0.001 0.335 0.664
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.001 0.335 0.664
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.001 0.335 0.664
E53.9 Vitamin B deficiency, unspecified
0.000 0.335 0.665
E05.8 Other thyrotoxicosis
0.001 0.344 0.655
E67 Other hyperalimentation
0.000 0.345 0.655
E68 Sequelae of hyperalimentation
0.000 0.345 0.655
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.350 0.650
E55.0 Rickets, active
0.000 0.350 0.650
E86 Volume depletion
0.000 0.351 0.649
E61 Deficiency of other nutrient elements
0.000 0.353 0.647
E78.4 Other hyperlipidaemia
0.000 0.357 0.643
E03.8 Other specified hypothyroidism
0.571 0.363 0.066
E02 Subclinical iodine-deficiency hypothyroidism
0.006 0.363 0.631
E66.1 Drug-induced obesity
0.000 0.367 0.633
E53.1 Pyridoxine deficiency
0.000 0.369 0.630
E53.0 Riboflavin deficiency
0.000 0.369 0.630
E56 Other vitamin deficiencies
0.000 0.373 0.627
E06.5 Other chronic thyroiditis
0.002 0.373 0.625
E06.4 Drug-induced thyroiditis
0.002 0.373 0.625
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.002 0.373 0.625
E06.1 Subacute thyroiditis
0.002 0.373 0.625
E06.0 Acute thyroiditis
0.002 0.373 0.625
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.540 0.379 0.081
E74 Other disorders of carbohydrate metabolism
0.000 0.379 0.620
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.395 0.605
E03.5 Myxoedema coma
0.502 0.401 0.097
E03.4 Atrophy of thyroid (acquired)
0.502 0.401 0.097
E03.3 Postinfectious hypothyroidism
0.502 0.401 0.097
E03.1 Congenital hypothyroidism without goitre
0.502 0.401 0.097
E03.0 Congenital hypothyroidism with diffuse goitre
0.502 0.401 0.097
E78.6 Lipoprotein deficiency
0.000 0.402 0.598
E10-E14 Diabetes mellitus
0.000 0.405 0.595
E78.3 Hyperchylomicronaemia
0.000 0.413 0.586
E83.3 Disorders of phosphorus metabolism
0.000 0.432 0.568
E85.8 Other amyloidosis
0.000 0.449 0.551
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.449 0.551
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.449 0.551
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.449 0.551
E88.9 Metabolic disorder, unspecified
0.000 0.457 0.543
E88.8 Other specified metabolic disorders
0.000 0.457 0.543
E88.3 Tumour lysis syndrome
0.000 0.457 0.543
E73 Lactose intolerance
0.000 0.461 0.539
E85.3 Secondary systemic amyloidosis
0.000 0.461 0.539
E78.1 Pure hyperglyceridaemia
0.000 0.461 0.539
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.462 0.537
E40-E46 Malnutrition
0.000 0.469 0.530
E80.4 Gilbert's syndrome
0.000 0.469 0.531
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.474 0.526
E78.8 Other disorders of lipoprotein metabolism
0.000 0.478 0.521
E11 Non-insulin-dependent diabetes mellitus
0.000 0.481 0.519
E85.9 Amyloidosis, unspecified
0.000 0.487 0.513
E05.9 Thyrotoxicosis, unspecified
0.000 0.496 0.504
E11.4 With neurological complications
0.000 0.506 0.494
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.517 0.482
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.517 0.482
E70.3 Albinism
0.000 0.517 0.482
E70.2 Disorders of tyrosine metabolism
0.000 0.517 0.482
E70.1 Other hyperphenylalaninaemias
0.000 0.517 0.482
E70.0 Classical phenylketonuria
0.000 0.517 0.482
E71.3 Disorders of fatty-acid metabolism
0.000 0.517 0.482
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.517 0.482
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.517 0.482
E71.0 Maple-syrup-urine disease
0.000 0.517 0.482
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.517 0.482
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.517 0.482
E72.5 Disorders of glycine metabolism
0.000 0.517 0.482
E72.4 Disorders of ornithine metabolism
0.000 0.517 0.482
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.517 0.482
E72.2 Disorders of urea cycle metabolism
0.000 0.517 0.482
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.517 0.482
E72.0 Disorders of amino-acid transport
0.000 0.517 0.482
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.517 0.482
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.517 0.482
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.517 0.482
E76.2 Other mucopolysaccharidoses
0.000 0.517 0.482
E76.1 Mucopolysaccharidosis, type II
0.000 0.517 0.482
E76.0 Mucopolysaccharidosis, type I
0.000 0.517 0.482
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.517 0.482
E77.8 Other disorders of glycoprotein metabolism
0.000 0.517 0.482
E77.1 Defects in glycoprotein degradation
0.000 0.517 0.482
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.517 0.482
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.517 0.482
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.517 0.482
E79.1 Lesch-Nyhan syndrome
0.000 0.517 0.482
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.517 0.482
E84.9 Cystic fibrosis, unspecified
0.000 0.517 0.482
E84.8 Cystic fibrosis with other manifestations
0.000 0.517 0.482
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.517 0.482
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.517 0.482
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.004 0.518 0.477
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.004 0.518 0.477
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.004 0.518 0.477
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.004 0.518 0.477
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.004 0.518 0.477
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.004 0.518 0.477
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.004 0.518 0.477
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.004 0.518 0.477
E50.9 Vitamin A deficiency, unspecified
0.000 0.521 0.479
E50.8 Other manifestations of vitamin A deficiency
0.000 0.521 0.479
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.521 0.479
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.521 0.479
E50.5 Vitamin A deficiency with night blindness
0.000 0.521 0.479
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.521 0.479
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.521 0.479
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.521 0.479
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.521 0.479
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.521 0.479
E51.9 Thiamine deficiency, unspecified
0.000 0.521 0.479
E51.8 Other manifestations of thiamine deficiency
0.000 0.521 0.479
E51.2 Wernicke's encephalopathy
0.000 0.521 0.479
E51.1 Beriberi
0.000 0.521 0.479
E63.9 Nutritional deficiency, unspecified
0.000 0.521 0.479
E63.8 Other specified nutritional deficiencies
0.000 0.521 0.479
E63.1 Imbalance of constituents of food intake
0.000 0.521 0.479
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.521 0.479
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.521 0.479
E64.8 Sequelae of other nutritional deficiencies
0.000 0.521 0.479
E64.3 Sequelae of rickets
0.000 0.521 0.479
E64.2 Sequelae of vitamin C deficiency
0.000 0.521 0.479
E64.1 Sequelae of vitamin A deficiency
0.000 0.521 0.479
E64.0 Sequelae of protein-energy malnutrition
0.000 0.521 0.479
E15 Nondiabetic hypoglycaemic coma
0.000 0.522 0.478
E16 Other disorders of pancreatic internal secretion
0.000 0.530 0.470
E67.8 Other specified hyperalimentation
0.000 0.530 0.470
E67.3 Hypervitaminosis D
0.000 0.530 0.470
E67.2 Megavitamin-B6 syndrome
0.000 0.530 0.470
E67.1 Hypercarotenaemia
0.000 0.530 0.470
E67.0 Hypervitaminosis A
0.000 0.530 0.470
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.534 0.466
E80.5 Crigler-Najjar syndrome
0.000 0.534 0.466
E80.3 Defects of catalase and peroxydase
0.000 0.534 0.466
E80.1 Porphyria cutanea tarda
0.000 0.534 0.466
E80.0 Hereditary erythropoietic porphyria
0.000 0.534 0.466
E61.9 Deficiency of nutrient element, unspecified
0.000 0.536 0.464
E61.8 Deficiency of other specified nutrient elements
0.000 0.536 0.464
E61.7 Deficiency of multiple nutrient elements
0.000 0.536 0.464
E61.6 Vanadium deficiency
0.000 0.536 0.464
E61.5 Molybdenum deficiency
0.000 0.536 0.464
E61.4 Chromium deficiency
0.000 0.536 0.464
E61.3 Manganese deficiency
0.000 0.536 0.464
E61.2 Magnesium deficiency
0.000 0.536 0.464
E61.0 Copper deficiency
0.000 0.536 0.464
E56.9 Vitamin deficiency, unspecified
0.000 0.550 0.450
E56.8 Deficiency of other vitamins
0.000 0.550 0.450
E56.0 Deficiency of vitamin E
0.000 0.550 0.450
E80.6 Other disorders of bilirubin metabolism
0.000 0.551 0.449
E88.2 Lipomatosis, not elsewhere classified
0.000 0.553 0.447
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.555 0.445
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.555 0.445
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.555 0.445
E74.2 Disorders of galactose metabolism
0.000 0.555 0.445
E74.1 Disorders of fructose metabolism
0.000 0.555 0.445
E74.0 Glycogen storage disease
0.000 0.555 0.445
E61.1 Iron deficiency
0.000 0.558 0.442
E75.6 Lipid storage disorder, unspecified
0.000 0.566 0.434
E75.5 Other lipid storage disorders
0.000 0.566 0.434
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.566 0.434
E75.3 Sphingolipidosis, unspecified
0.000 0.566 0.434
E75.1 Other gangliosidosis
0.000 0.566 0.434
E75.0 GM2 gangliosidosis
0.000 0.566 0.434
E12 Malnutrition-related diabetes mellitus
0.000 0.573 0.426
E56.1 Deficiency of vitamin K
0.000 0.591 0.409
E13 Other specified diabetes mellitus
0.000 0.592 0.407
E11.6 With other specified complications
0.000 0.603 0.396
K90 Intestinal malabsorption
0.000 0.604 0.396
E10 Insulin-dependent diabetes mellitus
0.000 0.607 0.393
E11.2 With renal complications
0.000 0.607 0.393
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.607 0.392
E16.2 Hypoglycaemia, unspecified
0.000 0.610 0.390
E11.0 With coma
0.000 0.611 0.389
E73.8 Other lactose intolerance
0.000 0.613 0.386
E73.1 Secondary lactase deficiency
0.000 0.613 0.386
E73.0 Congenital lactase deficiency
0.000 0.613 0.386
E11.8 With unspecified complications
0.000 0.618 0.382
E11.5 With peripheral circulatory complications
0.000 0.619 0.381
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.619 0.380
E45 Retarded development following protein-energy malnutrition
0.000 0.619 0.380
E43 Unspecified severe protein-energy malnutrition
0.000 0.619 0.380
E42 Marasmic kwashiorkor
0.000 0.619 0.380
E41 Nutritional marasmus
0.000 0.619 0.380
E40 Kwashiorkor
0.000 0.619 0.380
E11.7 With multiple complications
0.000 0.628 0.372
E10.2 With renal complications
0.000 0.628 0.372
L40-L45 Papulosquamous disorders
0.000 0.631 0.369
E75.2 Other sphingolipidosis
0.000 0.634 0.365
E80.2 Other porphyria
0.000 0.640 0.360
E07 Other disorders of thyroid
0.009 0.641 0.350
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.663 0.337
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.663 0.337
E16.4 Abnormal secretion of gastrin
0.000 0.663 0.337
E16.3 Increased secretion of glucagon
0.000 0.663 0.337
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.668 0.331
E16.1 Other hypoglycaemia
0.000 0.670 0.330
E11.3 With ophthalmic complications
0.000 0.675 0.325
E10.3 With ophthalmic complications
0.000 0.689 0.311
E12.9 Without complications
0.000 0.694 0.306
E12.8 With unspecified complications
0.000 0.694 0.306
E12.7 With multiple complications
0.000 0.694 0.306
E12.6 With other specified complications
0.000 0.694 0.306
E12.5 With peripheral circulatory complications
0.000 0.694 0.306
E12.4 With neurological complications
0.000 0.694 0.306
E12.3 With ophthalmic complications
0.000 0.694 0.306
E12.2 With renal complications
0.000 0.694 0.306
E12.1 With ketoacidosis
0.000 0.694 0.306
E12.0 With coma
0.000 0.694 0.306
E10.1 With ketoacidosis
0.000 0.696 0.304
E11.1 With ketoacidosis
0.000 0.698 0.302
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.699 0.301
E10.8 With unspecified complications
0.000 0.703 0.297
K90.8 Other intestinal malabsorption
0.000 0.706 0.294
E13.8 With unspecified complications
0.000 0.708 0.292
E13.7 With multiple complications
0.000 0.708 0.292
E13.6 With other specified complications
0.000 0.708 0.292
E13.5 With peripheral circulatory complications
0.000 0.708 0.292
E13.4 With neurological complications
0.000 0.708 0.292
E13.3 With ophthalmic complications
0.000 0.708 0.292
E13.2 With renal complications
0.000 0.708 0.292
E13.1 With ketoacidosis
0.000 0.708 0.292
E13.0 With coma
0.000 0.708 0.292
K90.3 Pancreatic steatorrhoea
0.000 0.716 0.284
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.716 0.284
K90.1 Tropical sprue
0.000 0.716 0.284
E10.7 With multiple complications
0.000 0.718 0.282
L42 Pityriasis rosea
0.000 0.723 0.277
E13.9 Without complications
0.000 0.727 0.273
E44.1 Mild protein-energy malnutrition
0.000 0.727 0.273
E44.0 Moderate protein-energy malnutrition
0.000 0.727 0.273
L44 Other papulosquamous disorders
0.000 0.735 0.265
L41 Parapsoriasis
0.000 0.735 0.265
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.735 0.265
E10.4 With neurological complications
0.000 0.735 0.265
E07.1 Dyshormogenetic goitre
0.006 0.743 0.251
E07.0 Hypersecretion of calcitonin
0.006 0.743 0.251
E73.9 Lactose intolerance, unspecified
0.001 0.747 0.252
E89.2 Postprocedural hypoparathyroidism
0.000 0.750 0.249
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.751 0.248
E04 Other non-toxic goitre
0.001 0.761 0.237
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.762 0.238
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.762 0.238
E89.5 Postprocedural testicular hypofunction
0.000 0.762 0.238
E89.1 Postprocedural hypoinsulinaemia
0.000 0.762 0.238
E46 Unspecified protein-energy malnutrition
0.001 0.763 0.236
E10.0 With coma
0.000 0.769 0.230
E11.9 Without complications
0.000 0.771 0.229
E89.4 Postprocedural ovarian failure
0.000 0.775 0.224
E10.5 With peripheral circulatory complications
0.000 0.778 0.222
E07.8 Other specified disorders of thyroid
0.006 0.778 0.215
L43 Lichen planus
0.000 0.781 0.219
K90.9 Intestinal malabsorption, unspecified
0.000 0.783 0.217
E89.3 Postprocedural hypopituitarism
0.000 0.785 0.215
E10.6 With other specified complications
0.000 0.795 0.204
L41.9 Parapsoriasis, unspecified
0.000 0.810 0.190
L41.8 Other parapsoriasis
0.000 0.810 0.190
L41.5 Retiform parapsoriasis
0.000 0.810 0.190
L41.4 Large plaque parapsoriasis
0.000 0.810 0.190
L41.3 Small plaque parapsoriasis
0.000 0.810 0.190
L41.2 Lymphomatoid papulosis
0.000 0.810 0.190
L41.1 Pityriasis lichenoides chronica
0.000 0.810 0.190
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.810 0.190
L44.9 Papulosquamous disorder, unspecified
0.000 0.810 0.190
L44.8 Other specified papulosquamous disorders
0.000 0.810 0.190
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.810 0.190
L44.3 Lichen ruber moniliformis
0.000 0.810 0.190
L44.2 Lichen striatus
0.000 0.810 0.190
L44.1 Lichen nitidus
0.000 0.810 0.190
L44.0 Pityriasis rubra pilaris
0.000 0.810 0.190
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.813 0.187
E14 Unspecified diabetes mellitus
0.000 0.817 0.183
E04.8 Other specified non-toxic goitre
0.001 0.829 0.170
L43.3 Subacute (active) lichen planus
0.000 0.843 0.157
L43.2 Lichenoid drug reaction
0.000 0.843 0.157
L43.1 Bullous lichen planus
0.000 0.843 0.157
L43.0 Hypertrophic lichen planus
0.000 0.843 0.157
E04.0 Non-toxic diffuse goitre
0.001 0.845 0.154
E20-E35 Disorders of other endocrine glands
0.000 0.846 0.154
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.846 0.154
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.851 0.149
T42.4 Benzodiazepines
0.000 0.852 0.148
L43.8 Other lichen planus
0.000 0.854 0.146
E04.1 Non-toxic single thyroid nodule
0.000 0.860 0.140
E14.8 With unspecified complications
0.000 0.868 0.131
E14.7 With multiple complications
0.000 0.868 0.131
E14.6 With other specified complications
0.000 0.868 0.131
E14.2 Withrenal complications
0.000 0.868 0.131
E14.0 With coma
0.000 0.868 0.131
E14.4 With neurological complications
0.000 0.869 0.131
E14.5 With peripheral circulatory complications
0.000 0.871 0.129
L43.9 Lichen planus, unspecified
0.000 0.872 0.128
E34 Other endocrine disorders
0.000 0.875 0.125
E27 Other disorders of adrenal gland
0.000 0.882 0.118
S64.4 Injury of digital nerve of other finger
0.118 0.882 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.884 0.116
E14.1 With ketoacidosis
0.000 0.886 0.113
E87 Other disorders of fluid, electrolyte and acid-base balance
0.000 0.889 0.111
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.889 0.110
E32 Diseases of thymus
0.000 0.889 0.110
E31 Polyglandular dysfunction
0.000 0.889 0.110
E30 Disorders of puberty, not elsewhere classified
0.000 0.889 0.110
E25 Adrenogenital disorders
0.000 0.889 0.110
E20 Hypoparathyroidism
0.000 0.890 0.110
E27.1 Primary adrenocortical insufficiency
0.000 0.890 0.109
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.892 0.108
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.893 0.107
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.893 0.107
T42.3 Barbiturates
0.000 0.893 0.107
T42.2 Succinimides and oxazolidinediones
0.000 0.893 0.107
T42.0 Hydantoin derivatives
0.000 0.893 0.107
E22 Hyperfunction of pituitary gland
0.000 0.894 0.106
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.894 0.106
T42.1 Iminostilbenes
0.000 0.895 0.105
E89.0 Postprocedural hypothyroidism
0.000 0.895 0.105
E34.0 Carcinoid syndrome
0.000 0.896 0.104
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.897 0.103
E14.3 With ophthalmic complications
0.000 0.897 0.103
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.898 0.102
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.898 0.102
E29 Testicular dysfunction
0.000 0.903 0.096
E34.8 Other specified endocrine disorders
0.000 0.905 0.095
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.905 0.095
E87.5 Hyperkalaemia
0.000 0.907 0.093
E27.8 Other specified disorders of adrenal gland
0.000 0.907 0.092
T43.2 Other and unspecified antidepressants
0.000 0.908 0.092
E26 Hyperaldosteronism
0.001 0.910 0.090
E34.5 Androgen resistance syndrome
0.000 0.910 0.090
E34.4 Constitutional tall stature
0.000 0.910 0.090
E34.3 Short stature, not elsewhere classified
0.000 0.910 0.090
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.910 0.090
E34.1 Other hypersecretion of intestinal hormones
0.000 0.910 0.090
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.911 0.088
T40.2 Other opioids
0.000 0.914 0.086
E04.2 Non-toxic multinodular goitre
0.000 0.915 0.085
E27.5 Adrenomedullary hyperfunction
0.000 0.915 0.085
E27.0 Other adrenocortical overactivity
0.000 0.915 0.085
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.915 0.085
E34.9 Endocrine disorder, unspecified
0.000 0.916 0.084
E22.0 Acromegaly and pituitary gigantism
0.000 0.916 0.083
T43.6 Psychostimulants with abuse potential
0.000 0.917 0.082
E22.1 Hyperprolactinaemia
0.000 0.918 0.082
E87.2 Acidosis
0.000 0.918 0.082
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.919 0.081
E87.4 Mixed disorder of acid-base balance
0.000 0.920 0.080
E25.9 Adrenogenital disorder, unspecified
0.000 0.920 0.079
E25.8 Other adrenogenital disorders
0.000 0.920 0.079
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.920 0.079
E30.9 Disorder of puberty, unspecified
0.000 0.920 0.079
E30.8 Other disorders of puberty
0.000 0.920 0.079
E30.1 Precocious puberty
0.000 0.920 0.079
E30.0 Delayed puberty
0.000 0.920 0.079
E31.9 Polyglandular dysfunction, unspecified
0.000 0.920 0.079
E31.8 Other polyglandular dysfunction
0.000 0.920 0.079
E31.1 Polyglandular hyperfunction
0.000 0.920 0.079
E31.0 Autoimmune polyglandular failure
0.000 0.920 0.079
E32.9 Disease of thymus, unspecified
0.000 0.920 0.079
E32.8 Other diseases of thymus
0.000 0.920 0.079
E32.1 Abscess of thymus
0.000 0.920 0.079
E32.0 Persistent hyperplasia of thymus
0.000 0.920 0.079
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.920 0.079
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.920 0.079
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.920 0.079
E20.8 Other hypoparathyroidism
0.000 0.921 0.079
E20.1 Pseudohypoparathyroidism
0.000 0.921 0.079
E20.0 Idiopathic hypoparathyroidism
0.000 0.921 0.079
E20.9 Hypoparathyroidism, unspecified
0.000 0.922 0.078
E28 Ovarian dysfunction
0.002 0.922 0.077
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.922 0.078
T43.9 Psychotropic drug, unspecified
0.000 0.922 0.078
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.922 0.078
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.922 0.078
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.924 0.076
E22.8 Other hyperfunction of pituitary gland
0.000 0.924 0.076
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.924 0.076
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.924 0.076
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.924 0.076
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.926 0.073
E24 Cushing's syndrome
0.001 0.927 0.072
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.927 0.073
E23 Hypofunction and other disorders of pituitary gland
0.001 0.928 0.072
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.929 0.071
T40.6 Other and unspecified narcotics
0.000 0.930 0.070
E29.9 Testicular dysfunction, unspecified
0.000 0.930 0.069
E29.8 Other testicular dysfunction
0.000 0.930 0.069
E29.0 Testicular hyperfunction
0.000 0.930 0.069
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.931 0.068
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.932 0.068
T40.8 Lysergide [LSD]
0.000 0.932 0.068
T40.7 Cannabis (derivatives)
0.000 0.932 0.068
T40.5 Cocaine
0.000 0.932 0.068
T40.3 Methadone
0.000 0.932 0.068
T40.1 Heroin
0.000 0.932 0.068
T40.0 Opium
0.000 0.932 0.068
E27.2 Addisonian crisis
0.000 0.933 0.067
T40.4 Other synthetic narcotics
0.000 0.933 0.067
E87.6 Hypokalaemia
0.000 0.934 0.066
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.934 0.066
E87.7 Fluid overload
0.000 0.934 0.066
E10.9 Without complications
0.000 0.935 0.065
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.935 0.065
E26.9 Hyperaldosteronism, unspecified
0.001 0.935 0.064
E26.8 Other hyperaldosteronism
0.001 0.935 0.064
E26.1 Secondary hyperaldosteronism
0.001 0.935 0.064
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.936 0.064
E87.0 Hyperosmolality and hypernatraemia
0.000 0.936 0.064
E27.9 Disorder of adrenal gland, unspecified
0.000 0.938 0.061
T36 Poisoning by systemic antibiotics
0.000 0.939 0.061
E28.3 Primary ovarian failure
0.001 0.940 0.058
T38.9 Other and unspecified hormone antagonists
0.000 0.941 0.058
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.941 0.058
T38.7 Androgens and anabolic congeners
0.000 0.941 0.058
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.941 0.058
T38.5 Other oestrogens and progestogens
0.000 0.941 0.058
T38.4 Oral contraceptives
0.000 0.941 0.058
T38.2 Antithyroid drugs
0.000 0.941 0.058
T38.1 Thyroid hormones and substitutes
0.000 0.941 0.058
T38.0 Glucocorticoids and synthetic analogues
0.000 0.941 0.058
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.942 0.058
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
0.000 0.943 0.057
E23.6 Other disorders of pituitary gland
0.000 0.943 0.057
E21.0 Primary hyperparathyroidism
0.000 0.943 0.057
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.943 0.057
E28.9 Ovarian dysfunction, unspecified
0.001 0.944 0.055
E28.8 Other ovarian dysfunction
0.001 0.944 0.055
E28.1 Androgen excess
0.001 0.944 0.055
E28.0 Oestrogen excess
0.001 0.944 0.055
E21.4 Other specified disorders of parathyroid gland
0.000 0.944 0.056
E21.2 Other hyperparathyroidism
0.000 0.944 0.056
E29.1 Testicular hypofunction
0.000 0.945 0.055
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.945 0.055
E07.9 Disorder of thyroid, unspecified
0.010 0.945 0.046
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.945 0.055
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.945 0.055
T47.7 Emetics
0.000 0.945 0.055

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.